MS Re has undergone a period of significant growth in recent years and expects to top $4bn in GWP by 2025. CUO Charlie Goldie explains on Behind the Headlines that the company’s strategy is to deliver ...

The bully in me met its match in my primary school classmate, Lukman Oluwuyi, on our way back home one afternoon. In the eyes of a schoolkid, St Paul ...

Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.

Fujiyama is a manufacturer of products and a solution provider in the rooftop solar industry, including on-grid, off-grid, ...